4
Changes in Ownership
CG Oncology, Inc. Filed Acc 0001684531-26-000002
Director sold 1,964 shares at $60.12 ($118,076)
- Director acquired 1,964 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mulay James · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +654 | $3.72 | $2,433 | 654 | D |
| 2026-06-15 | Sale : show line 2 in the form 10b5-1 | −654 | $60.12 | $39,318 | 0 | D |
| 2026-06-15 | Exercise or conversion : show line 3 in the form 10b5-1 | +1,310 | $12.59 | $16,493 | 1,310 | D |
| 2026-06-15 | Sale : show line 4 in the form 10b5-1 | −1,310 | $60.12 | $78,757 | 0 | D |
| Open-market sales · 1,964 sh · avg $60.12 · $118,076 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 5 in the form 10b5-1 Director Stock Option (right to buy) | −654 | 0 | D |
| 2026-06-15 | Exercise or conversion : show line 6 in the form 10b5-1 Director Stock Option (right to buy) | −1,310 | 2,620 | D |
Loading xslF345X06/form4-06162026_090604.xml…